Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression

References

• Bosworth HB, Bastian LA., Kuchibhatla MN, et al. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom Med 2001;63:603–8
   PubMed Web of Science ®Google Scholar
• Dennerstein L. Depression in the menopause. Obstet Gynecol Clin N Am 1987;4: 33–48
   Google Scholar
• Rosemeier HP. Psychosocial reflexions on the menopausal transition. Presented at the Sympo-sium: New Trends in Transdermal HRT and Climacteric Psychology, XV FIGO World Con-gress on Gynecology and Obstetrics, 4th August, 1997
   Google Scholar
• Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol 1994;4:214–20
   Google Scholar
• Avis NE, McKinlay SM. The Massachusetts Women's Health Study: an epidemiological investigation of the menopause. J Amn Med Women's Assoc 1995;50: 45-9,63
   Google Scholar
• Kaufert PA, Gilbert P, Tate R. The Manitoba-Project: A reexamination of the link between menopause and depression. Maturitas 1992;14: 143–55
   Google Scholar
• Sydow K, Reimer C. Psychosomatik der Meno-pause: Literaturitherblick 1988-1992. Psych o-therapie, Psychosomatik, Med Psychol 1995;45: 225–36
   PubMedGoogle Scholar
• Genazzani AR, Montelone P, Gambacciani M. Hormonal influence on the central nervous system. Maturitas 2002;43:11–17
   Google Scholar
• Halbreich U, Kahn LS. Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs 2001;15:797–817
   PubMed Web of Science ®Google Scholar
• Robinson GE. Psychotic and mood disorders associated with the perimenopausal period — epidemiology, aetiology and management. CNS Drugs 2001;15:175–84
   PubMed Web of Science ®Google Scholar
• Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189–221
   PubMed Web of Science ®Google Scholar
• Stoppe G, Dören M. Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood. Arch Womens Mental Health 2002;5:39–47
   PubMedGoogle Scholar
• Saletu B, Brandstätter N, Metka M, et al. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology 1995;122:321–9
   PubMed Web of Science ®Google Scholar
• Carranza-Lira S, Valentino-Figueroa ML. Estro-gen therapy for depression in postmenopausal women. Int J Gynecol Obstet 1999;65:35–8
   PubMed Web of Science ®Google Scholar
• Holsboer F, Benkert 0, Demisch L. Changes in MAO activity during estrogen treatment of females with endogenous depression. Modern Problems of Pharmaco psychiatry 1983;19:321–6
   Google Scholar
• Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in the perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183:414–20
   PubMed Web of Science ®Google Scholar
• Soares CD, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women — a double-blind, randomized, placebo-con-trolled trial. Arch Gen Psychiatry 2001;58:529–34
   PubMed Web of Science ®Google Scholar
• Watson NR, Studd JW, Savvas M, Baber RJ. The long-term effects of estradiol implant therapy for the treatment of premenstrual syndrome. Gynecol Endocrinol 1990;4:99–107
   PubMed Web of Science ®Google Scholar
• Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JWW. Transdermal estrogen for treatment of severe postnatal depression. Lancet 1996;347:930–3
   Google Scholar
• Henderson AF, Gregoire AJ, Kumar RD, Studd JW. Treatment of severe postnatal depression with oestradiol skin patches. Lancet 1991; 338:816–17
   PubMed Web of Science ®Google Scholar
• Klaiber EL, Broverman DM, Vogel W, Kobaya-shi V. Estrogen for severe persistent depression in women. Arch Gen Psychiatry 1979;36: 550–4
   PubMed Web of Science ®Google Scholar
• Best NR, Rees MP, Barlow DH, Cowen PJ. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 1992;17:87–93
   PubMed Web of Science ®Google Scholar
• Blum I, Vered Y, Lifshitz A, et al. The effect of estrogen replacement therapy on plasma seroto-nin and catecholamines of postmenopausal women. Israel J Med Sci 1996;32:1158–62
   PubMedGoogle Scholar
• Henderson VW. Hormone Therapy and The Brain: A Clinical Perspective on the Role of Estrogen. New York: Parthenon Publishing, 2000
   Google Scholar
• Halbreich U, Rojanski N, Palter S, et al. Estrogen augments serotonergic activity in post-menopausal women. Biol Psychiatry 1995;37: 434–41
   PubMed Web of Science ®Google Scholar
• Lippert TH, Filshie M, Mueck AO, et al. Serotonin metabolite excretion after postmeno-pausal estradiol therapy. Maturitas 1996;24: 37–41
   PubMed Web of Science ®Google Scholar
• Mueck AO, Seeger H, Kasspohl-Butz S, et al. Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women. Horm Metab Res 1997;29:80–3
   Google Scholar
• Parry BL, Newton RP. Chronobiological basis of female-specific mood disorders. Neuropsycho-pharmacology 2001;25:102–8
   PubMed Web of Science ®Google Scholar
• Rasgon NL, Altshuler LL, Fairbanks LA, et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 2002;63:45–8
   PubMed Web of Science ®Google Scholar
• Schneider LS, Small GW, Hamilton SH. Estro-gen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine collaborative study group. Am J Geriatr Psy-chiatry 1997;5:97–106
   Google Scholar
• Stahl SM. Augmentation of antidepressants by estrogen. Psychopharmacol Bull 1998;34:319–21
   PubMed Web of Science ®Google Scholar
• Westlund L, Parry BL. Does estrogen enhance the antidepressant effects of fluoxetine? J Affect Disorders 2003;77:87–92
   PubMed Web of Science ®Google Scholar
• Panay N., Studd JWW. The psychotherapeutic effects of estrogens. Gynecol Endocrinol 1998;12:353–65
   PubMed Web of Science ®Google Scholar
• Meyers BS, Moline ML. The role of estrogen in late-life depression: opportunities and barriers to research. Psychopharmacol Bull 1997;33: 289–91
   PubMed Web of Science ®Google Scholar
• Dell DL, Stewart DE. Menopause and mood: is depression linked with hormone changes? Post-grad Med 2000;108:34–43
   PubMed Web of Science ®Google Scholar
• Haynes P, Parry BL. Mood disorders and the reproductive cycle: affective disorders during the menopause and premenstrual dysphoric disor-der. Psychopharmacol Bull 1998;34:313–18
   PubMed Web of Science ®Google Scholar
• Morse CA, Dudley E, Guthrie J, Dennerstein L. Relationships between premenstrual complaints and perimenopausal experiences. J Psychosomat Obstet Gynecol 1998;19:182–91
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Nieman LK, Danaeau MA, et al. Differential behavioral effects of gonadal ster-oids in women with and those without premenstrual syndrome. N Engl J Med 1998;338:209–16
   PubMed Web of Science ®Google Scholar
• Hunter M. The Women's Health Questionnaire (WHQ): the development, standardization and application of a measure of mid-aged women's emotional and physical health. Quality of Life Res 2000;9:733–8
   Web of Science ®Google Scholar
• Gräser T, Hoffmann H, Zimmermann H, Oettel M. Lafamme®: a new oral preparation for continuous combined hormone replacement therapy in postmenopausal women. Drugs To-day 2001;37( G ) : 17–27
   Google Scholar
• Oettel M, Carol W, Elger W, et al. A 19-norprogestin without 17a-ethinyl group II: dienogest from a pharmacodynamic point of view. Drugs Today 1995;31:517–36
   Google Scholar
• Saletu B. Veränderungen von Vigilanz, kognitiver Informationsverarbeitung und Schlafqualität un-ter Climodien ®. Gyne 2001;September:258–64
   Google Scholar
• Saletu B, Anderer P, Gruber G, et al. Insomnia related to postmenopausal syndrome: sleep laboratory studies on differences between pa-tients and normal controls, and influence of an estrogen-progestogen combination with dieno-gest versus estrogen alone and placebo. Drugs Today 2001;37(G):39–62
   Google Scholar
• Weinfurt KP. Repeated measures analyses: AN-OVA, MANOVA, and HLM. In Grimm LG, Yarnold PR, eds. Reading and Understanding More Multivariate Statistics. Washington DC: American Psychological Association (APA), 2000:317–61
   Google Scholar
• Björn I, Sundström-Poromaa I, Bixo M, et al. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J Clinl Endocrinol Metab 2003;88:2026–30
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Neri I, Tarabusi M, et al. Effect of long-term local or systemic hormone replace-ment therapy on post-menopausal mood disturbances. Influences of socio-economic and personality factors. Maturitas 1999;31: 111–16
   Google Scholar
• Dennerstein L, Burrows GD. Psychological effects of progestogens in the postmenopausal years. Maturitas 1986;8:101–06
   PubMed Web of Science ®Google Scholar
• Girdler SS, O'Briant C, Steege J, et al. A comparison of the effect of estrogen with or without progesterone on mood and physical symptoms in postmenopausal women. J Wo-men's Health Gender-Based Med 1999;8:637–46
   PubMedGoogle Scholar
• Klaiber EL, Broverman DM, Vogel W, et al. Relationships of the serum estradiol levels, menopausal duration, and mood during hormo-nal replacement therapy. Psychoneuro-endocrinology 1997;22:549–58
   PubMed Web of Science ®Google Scholar
• Sherwin B. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336–43
   PubMed Web of Science ®Google Scholar
• Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;349:1839–54
   Google Scholar
• Wolf OT, Kudielka BM, Hellhammer DH, et al. Two weeks of transdermal estradiol treatment in postmenopausal women and its effect on mem-ory and mood: verbal memory changes are associated with the treatment induced estradiol increase. Psychoneuroendocrinology 1999;24: 727–41
   PubMed Web of Science ®Google Scholar
• Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. J Am Med Assoc 2002;287:1840–7
   PubMed Web of Science ®Google Scholar
• Khan A, Leventhal RM, Khan SR, Brown WA. Severity of depression and response to antide-pressants and placebo: an analysis of the Food and Drug Administration Database. J Clin Psychopharmacol 2002;2:40–5
   Google Scholar
• Göretzlehner G, Lauritzen C. Praktische Hor-montherapie in der Gynäkologie. Berlin: Walter de Gruyter, 1995:323–43
   Google Scholar
• McClelland GH, Judd CM. Statistical difficulties of detecting interactions and moderator effects. Psychol Bull 1993;114:376–90
   PubMed Web of Science ®Google Scholar